Phosphatidylserine Supplement Contract Manufacturer
From raw material selection to commercial production, we help supplement brands launch differentiated phosphatidylserine products with clinically aligned formulations, premium raw materials, and scalable manufacturing.
Why Choose KS Nutripharma for PS Manufacturing
- Soy & Sunflower PS Sourcing — Non-GMO, allergen-free options with full traceability
- 20%/50%/70% Purity Grades — Flexible specifications to match your positioning and cost targets
- Capsules/Gummies/Softgels/Powder/Tablets — Full-format manufacturing under one roof
- MOQ from 25 kg (bulk powder) to 100,000+ units (finished goods)
- FDA-Registered Facility/GMP/ISO 22000/ HACCP Certified
- Global Regulatory Support — FDA, EFSA, TGA, NHP, Halal, Kosher
- In-House HPLC Laboratory — Batch-specific CoA with every shipment
Mature Formulations-NOOTROPIC & COGNITIVE ENHANCEMENT
Mature Formulations-STRESS, MOOD & ADAPTOGENIC
Mature Formulations-SLEEP & CIRCADIAN
Mature Formulations-SPORTS PERFORMANCE & RECOVERY
Mature Formulations-ANTI-INFLAMMATORY & NEUROPROTECTION
Mature Formulations-GUT-BRAIN AXIS & MICROBIOME
Mature Formulations-IMMUNE-NEURO & SPECIALIZED
Mature Formulations-EMERGING & NICHE TRENDS
Mechanism: Reishi is known as the “mushroom of immortality” — it provides immunomodulation (both immune enhancement and regulation), anxiolytic effects via GABAergic modulation, and sleep quality improvement. Turkey Tail (Trametes versicolor) provides PSK and PSP polysaccharides with documented immune-enhancing properties. PS 100 mg supports the neuronal membranes that benefit from reduced inflammatory load and improved sleep quality.
Formula:
- PS (sunflower): 100 mg
- Reishi extract (30% polysaccharides, 5% triterpenes): 500 mg
- Turkey Tail extract (40% polysaccharides): 500 mg
- Maitake extract (30% polysaccharides): 250 mg (additional beta-glucan source)
Format: Capsule
Clinical Anchor: Reishi demonstrated immunomodulatory, anxiolytic, and sleep-promoting effects in clinical trials. Turkey Tail PSK is an approved adjuvant cancer therapy in Japan. PS 100 mg addresses the cognitive dimension of immune health. This is the “mushroom adaptogen + phospholipid” approach to brain-immune wellness.
Positioning: “Mushroom Wisdom for the Modern Mind” — ancient fungi meet modern phospholipid science.
Mechanism: NAD+ declines by approximately 50% by age 50, impairing sirtuin activity (SIRT1, SIRT3), DNA repair, and mitochondrial function. NMN is the most direct and bioavailable NAD+ precursor. TMG (trimethylglycine) provides methyl groups to support the methylation cycle that NMN consumption can deplete. PS activates SIRT1-PGC-1α (which requires NAD+ as a cofactor), creating a synergistic “fuel + substrate” relationship.
Formula:
- PS (sunflower): 100 mg
- NMN (β-Nicotinamide Mononucleotide, 99% purity): 500 mg
- TMG (Trimethylglycine): 500 mg (methylation support)
- Trans-Resveratrol: 250 mg (SIRT1 activator, requires NAD+ for full effect)
Format: Capsule
Clinical Anchor: NMN 500 mg improved NAD+ levels and various markers of aging in human trials (Imai & Guarente, 2016; Igarashi et al., 2022). PS SIRT1-PGC-1α activation documented in 2025 requires NAD+ as a sirtuin cofactor. TMG prevents methylation depletion from high-dose nicotinamide metabolism. Resveratrol directly activates SIRT1. This is the “NAD+ Brain Stack.”
Positioning: “NAD+ Brain Restoration” — restore the cellular energy currency of your neurons.
Mechanism: Lion’s Mane contains hericenones and erinacines — unique compounds that stimulate Nerve Growth Factor (NGF) synthesis and promote myelination. Unlike most nootropics that work on neurotransmitter systems, Lion’s Mane actually promotes structural neural growth. PS provides the phospholipid building blocks (particularly for myelin sheaths, which are 70% lipid) that this new growth requires. This is the “growth + substrate” paradigm.
Formula:
- PS (sunflower): 100 mg
- Lion’s Mane (fruiting body + mycelium, 5% hericenones + erinacines): 1,000 mg
- N-Acetyl Cysteine (NAC): 600 mg (antioxidant protection during growth)
- Omega-3 (DHA): 500 mg (additional membrane building block)
Format: Capsule
Clinical Anchor: Lion’s Mane 1,000-3,000 mg improved cognitive function in elderly with mild cognitive impairment (Mori et al., 2009) and accelerated nerve regeneration in preclinical models. PS 100 mg provides phospholipid substrate for myelination. NAC protects newly forming neurons from oxidative stress. DHA is essential for synaptic membrane formation. This is the “neuroplasticity support” stack.
Positioning: “Neuroplasticity Support” — not just protecting neurons, but growing new connections.
Phosphatidylserine (PS) is a naturally occurring phospholipid and critical structural component of cell membranes, with particularly high concentrations in neuronal tissue. In the human brain, PS accounts for approximately 7-10% of total phospholipids and is essential for maintaining membrane fluidity, receptor function, and signal transduction.
What Makes PS Commercially Attractive
- FDA Qualified Health Claim: The FDA has authorized a qualified health claim stating that consumption of phosphatidylserine may reduce the risk of cognitive dysfunction in the elderly — a rare regulatory distinction among nootropic ingredients.
- Dual-Mechanism Positioning: Unlike single-pathway nootropics, PS supports both cognitive function (cholinergic receptor modulation) and stress response (HPA axis cortisol attenuation) — enabling two distinct product lines from one ingredient.
- Clinically Validated Dosages: Human trials at 100-600 mg/day provide substantiation for structure/function claims that withstand regulatory scrutiny.
- Growing Market Demand: Global PS market expanding at 6.5-8.0% CAGR, with sunflower-derived PS growing 35% annually in premium segments.
Key Benefits Summary
| Benefit Category | Clinical Evidence | Target Demographic |
| Memory Support | 300 mg/day improves verbal recall in mild cognitive impairment | Adults 50+ |
| Focus & Attention | 200 mg/day improves ADHD symptom scores in children | Students, professionals |
| Cortisol Modulation | 600 mg/day reduces exercise-induced cortisol by 39% | Athletes, stressed professionals |
| Healthy Aging | SIRT1-PGC-1alpha pathway activation supports mitochondrial function | Longevity-focused consumers 40+ |
| Sleep Support | 100-200 mg evening dose attenuates stress-related sleep disruption | Insomnia-stressed adults |
Raw material selection is one of the most consequential decisions in PS product development. The source of lecithin determines allergen profile, GMO status, cost structure, supply chain stability, and front-of-pack positioning. We offer all three tiers: soy-derived, sunflower-derived, and branded ingredient options.
Soy-Derived Phosphatidylserine
- Supply Chain: Highly stable with large-scale production in the U.S., Brazil, and Argentina; suitable for mass-market and high-volume contracts.
- Specifications: 20%, 50%, 70% PS purity; off-white fine powder (60 mesh); moisture <= 2.0%.
- Certifications: Non-GMO soy options; ISO 22000, HACCP, Kosher, Halal.
- Cost Position: Lowest raw material cost per kg; ideal for entry-level and mid-market products.
- Considerations: Contains soy allergens; may not suit thyroid-conscious consumers due to phytoestrogen concerns.
Sunflower-Derived Phosphatidylserine
- Supply Chain: Primarily Eastern Europe; slightly less stable than soy but adequate for contract manufacturing volumes.
- Specifications: Equivalent purity tiers (20%, 50%, 70%); comparable HPLC assay to soy.
- Certifications: Non-GMO by default; vegan, vegetarian, clean-label.
- Cost Position: 15-25% premium over soy; justified by allergen-free and clean-label advantages.
- Considerations: Preferred for children’s products, senior formulas, and soy-allergic populations.
Branded Ingredient Options
| Criteria | Sharp-PS (Soy) | Sharp-PS GREEN (Sunflower) | SerinAid | Generic |
| Source | Soy | Sunflower | Soy | Variable |
| Clinical Validation | Extensive | Growing | Moderate | Limited |
| Supply Chain | Full traceability | Full traceability | Full traceability | Variable |
| Regulatory Support | FDA QHC dossier, GRAS | Novel Food consultation | GRAS status | Supplier-dependent |
| Marketing Support | Trademark licensing | Non-GMO positioning | Clinical summaries | None |
| Cost Premium | 30-40% above generic | 40-50% above generic | 25-35% above generic | Baseline |
| Best For | Premium clinical brands | Clean-label premium | Sports & practitioner | Budget/entry-level |
Our manufacturing capabilities support the full clinically validated dosage range, with in-house stability testing to confirm potency throughout the stated shelf life.
| Dosage | Clinical Application | Best Format | Target Consumer |
| 100 mg | Standard unit dose; 3x daily = 300 mg protocol for memory trials | Capsules, gummies, multi-ingredient stacks | Entry-level cognitive support, seniors |
| 200 mg | ADHD pediatric studies; single-capsule adult maintenance | Capsules, chewables, gummies | Children’s focus, single-capsule daily products |
| 300 mg | Clinical strength; total daily dose from major cognitive trials | Capsules (size 00/000), softgels | Premium nootropics, practitioner channel |
| 400-600 mg | Cortisol blunting (600 mg showed 39% reduction); sports recovery | Powder, capsules, softgels | Athletes, high-stress professionals |
Dosage Formulation Guidance
- PS is fat-soluble — encapsulate in softgels with MCT oil or sunflower oil for enhanced bioavailability.
- Include PS in powder blends with lipophilic carriers (lecithin granules) for beverage applications.
- Co-formulate with omega-3 fatty acids (DHA/EPA) to leverage documented synergistic membrane effects.
Our phosphatidylserine manufacturing platform is purpose-built for phospholipid handling — addressing the specific physicochemical challenges that generic contract manufacturers often fail to manage.
Purpose-Built PS Manufacturing Infrastructure
| Capability | Description | Quality Outcome |
| Moisture-Controlled Powder Processing | Dehumidified production environment (<45% RH) with real-time humidity monitoring | Prevents hygroscopic caking and potency degradation |
| Nitrogen Protection Filling | N2 flushing of bulk powder storage and finished product packaging | Eliminates oxidative degradation; extends shelf life to 24+ months |
| Lipid Oxidation Control | Antioxidant stabilization systems (mixed tocopherols, rosemary extract, ascorbyl palmitate) | Prevents rancidity, off-odors, and consumer returns |
| High Uniformity Blending | V-blender and tumble mixer validation with stratified sampling; in-line NIR spectroscopy | Content uniformity RSD <6.0% per USP <905> |
| Particle Size Engineering | Micronization and custom particle sizing (60-100 mesh standard) | Consistent flow properties and capsule fill weights |
| Low Water Activity Manufacturing | Controlled water activity (aw <0.30) throughout production | Microbial stability without excessive heat treatment |
| Cold-Chain Bulk Storage | Raw material warehousing at 15-20 degrees C with humidity control | Preserves PS potency prior to production |
| In-House HPLC Laboratory | Quantitative PS assay using USP-grade reference standards | Batch-specific CoA with every shipment; label claim accuracy +/-5% |
Quality Systems & Certifications
- FDA Facility Registration & cGMP Compliance — Regular third-party audits
- ISO 22000:2018 Food Safety Management System
- HACCP Certification — Critical control points for phospholipid manufacturing
- Halal & Kosher Certification — Available for all PS grades and dosage forms
- Non-GMO Project Verification — For sunflower-derived and certified non-GMO soy PS
- Third-Party Lab Testing — Heavy metals (ICP-MS), microbiology (USP <2021>/<2022>), residual solvents (USP <467>)
Capsules (Hard Shell & Softgel)
Hard-shell vegetarian capsules (HPMC or pullulan) for clean-label positioning; softgels for oil-based co-delivery (PS + DHA + vitamin E). Sizes 4 through 000 with banding, enteric coating, and delayed-release options.
- MOQ: 100,000 capsules per SKU | Lead Time: 4-6 weeks
Tablets
Coated tablets, chewables, and effervescent tablets. PS tablets require careful compression parameter optimization due to hygroscopic properties. Our R&D team has validated tablet formulations up to 300 mg per tablet.
- MOQ: 100,000 tablets per SKU | Lead Time: 4-6 weeks
Gummies
Fastest-growing segment in cognitive health. Pectin-based vegan matrices with natural flavor masking and antioxidant stabilization. Typical potency: 100 mg per piece.
- MOQ: 50,000 gummies per SKU | Lead Time: 6-8 weeks
Liquid & Suspensions
Micro-emulsification and liposomal delivery technologies for enhanced dispersion and stability in aqueous systems. Liposomal PS supports premium positioning with bioavailability claims.
- MOQ: 5,000 units | Lead Time: 4-6 weeks
Bulk Powder
25 kg cartons with double-layer food-grade liners, full CoA, MSDS, and allergen statements. Custom particle sizing available.
- MOQ: 25 kg | Lead Time: 2-3 weeks
The following matrix summarizes the compatibility of phosphatidylserine with common co-ingredients in cognitive health and stress-management formulations. Use this as a starting point for your product development discussions.
| Co-Ingredients | Compatibility | Synergy Mechanism | Recommended Ratio (PS:Co) |
| DHA / Omega-3 | Excellent | Membrane structural synergy; PS enhances DHA incorporation into neuronal membranes | 1:2 to 1:5 |
| Citicoline (CDP-Choline) | Excellent | Dual phospholipid pathway — PS for membrane integrity, citicoline for phosphatidylcholine synthesis | 1:2.5 |
| Alpha GPC | Excellent | Cholinergic support — PS modulates receptors, Alpha GPC provides choline precursor | 1:3 |
| Bacopa Monnieri | Excellent | Memory consolidation (Bacopa) + membrane support (PS); complementary timeframes | 1:3 |
| Ginkgo Biloba | Excellent | Cerebral circulation (Ginkgo) + membrane fluidity (PS) | 1:1.2 |
| Lion’s Mane | Good | NGF stimulation (Lion’s Mane) + membrane substrate (PS) | 1:5 |
| L-Theanine | Excellent | Calm focus (L-Theanine) + cortisol modulation (PS); complementary stress mechanisms | 1:1 to 1:2 |
| Ashwagandha (KSM-66) | Excellent | Dual cortisol pathway — PS blunts acute cortisol spike, Ashwagandha lowers chronic cortisol | 1:1.5 |
| Rhodiola Rosea | Good | Fatigue resistance (Rhodiola) + HPA axis support (PS) | 1:1 |
| Magnesium (Glycinate) | Good | GABA modulation (Mg) + membrane support (PS); both support sleep quality | 1:2 |
| CoQ10 (Ubiquinol) | Good | Mitochondrial support (CoQ10) + membrane phospholipid (PS) | 1:1 |
| Uridine Monophosphate | Good | Synaptic plasticity (Uridine) + membrane substrate (PS); ‘Mr. Happy Stack’ variant | 1:1.5 |
| Resveratrol | Good | SIRT1 activation (Resveratrol) + SIRT1-PGC-1alpha pathway modulation (PS) | 1:1 |
| Vitamin E (Tocopherols) | Excellent | Lipid peroxidation defense; essential antioxidant for phospholipid stability | 1:0.3 |
Formulation Notes
- PS + DHA combinations should use antioxidant-stabilized softgels to prevent phospholipid oxidation.
- Ashwagandha-PS stacks at 2:1 weight ratio have shown synergistic cortisol modulation in preclinical models.
- All combination products require ICH Q1A accelerated stability testing (40 degrees C / 75% RH, 6 months) to confirm shelf-life potency.
- PS is fat-soluble — formulate with dietary fat, MCT oil, or emulsified delivery systems for optimal bioavailability.
Every phosphatidylserine production lot is tested against the following Critical Quality Attributes. These specifications ensure batch-to-batch consistency, regulatory compliance, and finished product stability.
| Quality Attribute | Specification (20% PS) | Specification (50% PS) | Specification (70% PS) | Test Method |
| PS Assay (HPLC) | >=20.0% | >=50.0% | >=70.0% | HPLC vs USP Reference |
| Moisture / Loss on Drying | <=2.0% | <=2.0% | <=2.0% | USP <731> |
| Peroxide Value | <=5.0 meq O2/kg | <=5.0 meq O2/kg | <=5.0 meq O2/kg | AOCS Cd 8b-90 |
| Heavy Metals (Pb) | <=1.0 ppm | <=1.0 ppm | <=1.0 ppm | ICP-MS |
| Heavy Metals (As) | <=1.0 ppm | <=1.0 ppm | <=1.0 ppm | ICP-MS |
| Heavy Metals (Cd) | <=0.5 ppm | <=0.5 ppm | <=0.5 ppm | ICP-MS |
| Heavy Metals (Hg) | <=0.1 ppm | <=0.1 ppm | <=0.1 ppm | ICP-MS |
| Total Plate Count | <=10,000 CFU/g | <=10,000 CFU/g | <=10,000 CFU/g | USP <2021> |
| Yeast & Mould | <=1,000 CFU/g | <=1,000 CFU/g | <=1,000 CFU/g | USP <2021> |
| E. coli | Absent in 10g | Absent in 10g | Absent in 10g | USP <2022> |
| Salmonella | Absent in 10g | Absent in 10g | Absent in 10g | USP <2022> |
| Residual Solvents | <=50 ppm (hexane, acetone) | <=50 ppm | <=50 ppm | USP <467> / GC-MS |
| Flowability | Free-flowing powder | Free-flowing powder | Free-flowing powder | Visual / Angle of Repose |
| Bulk Density | 0.3-0.6 g/mL | 0.3-0.6 g/mL | 0.3-0.6 g/mL | USP <616> |
| Particle Size (D90) | <=250 microns | <=250 microns | <=250 microns | Laser Diffraction |
Note: Custom specifications available upon request. All CoA documentation includes actual test results, reference standards, and analyst signatures.
Phosphatidylserine is not a trivial ingredient to formulate. Its physicochemical properties create specific manufacturing challenges that directly impact product quality, shelf life, and consumer satisfaction. B2B buyers should evaluate manufacturing partners based on demonstrated ability to solve these challenges.
Challenge 1: Hygroscopicity & Moisture Absorption
PS powder readily absorbs moisture from ambient air, leading to clumping, caking, and potency degradation. Traditional PS powders become unworkable in humid environments (>60% RH).
Our Solution: Non-hygroscopic PS grades + dehumidified production (<45% RH) + nitrogen flushing + desiccant integration in every bottle.
Challenge 2: Phospholipid Oxidation & Rancidity
Polyunsaturated fatty acid chains in PS are susceptible to lipid peroxidation, producing off-odors, rancid flavors, and harmful oxidation products. Consumer reviews consistently cite ‘fishy smell’ and ‘softgel leakage’ as reasons for returns.
Our Solution: Antioxidant stabilization (mixed tocopherols, rosemary extract, ascorbyl palmitate) + oxygen-barrier packaging (amber glass, nitrogen-flushed pouches) + cold-chain bulk storage at 15-20 degrees C.
Challenge 3: Tablet Compression & Flow Properties
PS powder has poor flow characteristics, low bulk density, and adhesive properties that make direct compression challenging. Wet granulation is generally avoided due to PS sensitivity to heat and moisture.
Our Solution: Dry granulation (roller compaction) + optimized excipient blends (SMCC, colloidal SiO2) + validated direct compression protocols with in-process weight, hardness, and friability monitoring.
Challenge 4: Content Uniformity & Potency Variability
PS powders exhibit particle size variability and electrostatic charging, leading to content uniformity issues. ConsumerLab’s 2024 testing found one PS product at only 10% of label claim — a catastrophic quality failure.
Our Solution: Micronization + particle size standardization (60-100 mesh) + V-blender validation with stratified sampling + in-line NIR spectroscopy + batch-specific HPLC assay against USP reference standards.
Challenge 5: Oil Extraction & Softgel Integrity
Temperature fluctuations during storage cause phase separation, oil leakage, or capsule deformation in PS softgels — a leading cause of retail returns.
Our Solution: Emulsifier stabilization (lecithin, polysorbate 80) + optimized gelatin bloom strength + ICH Q1A accelerated stability testing (40 degrees C / 75% RH, 6 months) + optional band-sealing for premium products.
Challenge 6: Gummy Manufacturing
PS has a characteristic phospholipid odor and bitter aftertaste. Heat during gummy production (80-100 degrees C) can degrade PS if not controlled.
Our Solution: Natural citrus/berry flavor masking with bitterness blockers + low-temperature pectin processing (<60 degrees C) + microencapsulated PS in modified starch + antioxidant coating on finished gummies.
Accelerated Stability Data — PS 50% Powder
The following data represents typical accelerated stability results for our phosphatidylserine 50% powder under ICH Q1A conditions. Actual CoA provided with every batch.
| Parameter | Initial (T0) | 3 Months (40C/75%RH) | 6 Months (40C/75%RH) | Specification |
| PS Assay (HPLC) | 51.2% | 50.8% | 50.1% | >=50.0% |
| Moisture | 1.4% | 1.5% | 1.6% | <=2.0% |
| Peroxide Value | 2.1 meq/kg | 2.8 meq/kg | 3.4 meq/kg | <=5.0 meq/kg |
| Total Plate Count | <100 CFU/g | <100 CFU/g | <100 CFU/g | <=10,000 CFU/g |
| Appearance | Off-white powder | Off-white powder | Slightly cream powder | Off-white to cream |
Case Study: US Nootropic Brand — PS Stress-Recovery Formula
The following case study illustrates a typical OEM project from formulation to commercial production.
Goal: Launch a premium PS-based cortisol-management supplement for the sports nutrition and executive wellness market within 4 months.
Challenge
- Required soy-free positioning (target demographic: health-conscious millennials and Gen Z)
- Needed stability data to support 24-month shelf life claim
- Gummy format requested for differentiation in saturated capsule market
- Required Informed Sport certification for athlete market credibility
Solution
- Selected Sharp-PS GREEN (sunflower-derived, non-GMO, soy-free) at 200 mg per serving
- Developed pectin-based vegan gummy with natural citrus flavor masking and vitamin E antioxidant stabilization
- Completed ICH Q1A accelerated stability (6 months) and real-time stability (12 months) with passing results
- Third-party Informed Sport certification with banned substance testing
- Low-temperature production process (<60 degrees C) to preserve PS potency through gummy manufacturing
Outcome
- Product launched on-time within 4-month timeline
- 24-month shelf life substantiated with full stability report
- Informed Sport certification enabled marketing to collegiate and professional athletes
- Product achieved 4.6/5 star rating on Amazon within first 6 months; <2% return rate
- Brand re-ordered 3x volume for second production run and expanded to 2 additional SKUs
The global phosphatidylserine market is valued at approximately USD 130-178 million in 2026, projected to reach USD 260-272 million by 2033-2035 (CAGR 6.5-8.0%). North America holds ~40% share, Europe ~30%, with Asia Pacific as the fastest-growing region.
Key Growth Drivers
- Aging demographics — 80% of world’s population over 60 will live in low/middle-income countries by 2050
- Post-pandemic cognitive health awareness (‘brain fog’ mainstreaming)
- Biohacking and executive wellness culture driving premium nootropic demand
- Women’s menopause cognition market — under-served with strong willingness to pay
- Sports recovery mainstreaming — cortisol management expanding beyond elite athletes
OEM Implications
- Dietary Supplements: 50% of market — dominant channel for capsules, tablets, softgels, powders
- Functional Foods: 25-40% — fastest-emerging segment (fortified beverages, nutrition bars)
- Powder dominates with 66-73% market share due to manufacturing flexibility; gummies show fastest growth among finished formats
- Sunflower-derived PS growing 35% annually in premium segments — clean-label, allergen-free driver
What Consumers Love
- ‘Improved mental clarity and reduced brain fog’ — most commonly cited benefit, 2-4 week onset
- ‘Better sleep quality and lower anxiety levels’ — prominent at 100-200 mg doses
- ‘Noticeable memory improvement after 8+ weeks’ — delayed gratification; satisfied users emphasize consistency
- ‘No jitters or crash’ — major differentiator vs. caffeine-based nootropics
- Sunflower-derived PS receives disproportionately positive sentiment for allergen-free positioning
Key Pain Points (OEM Opportunities)
| Consumer Pain Point | Manufacturing Solution | Competitive Advantage |
| Soy allergy concerns | Use sunflower-derived PS | Clean-label, allergen-free positioning |
| Softgel leakage / rancid odor | Nitrogen flushing + antioxidant stabilization + barrier packaging | Extended shelf life, premium quality |
| GI discomfort at high doses | Enteric coating or microencapsulation with MCT oil | Improved tolerability, higher compliance |
| Multi-capsule daily dosing | Develop 200-300 mg single-capsule formulations | Reduced pill burden, higher retention |
| No immediate effect / poor value | Bundle with fast-acting ingredients (L-theanine) + education insert | Dual-action perception, reduced churn |
| Oxidation / potency concerns | Third-party HPLC + QR-linked CoA on every bottle | Transparency, trust, premium pricing |
The following decision framework maps the typical procurement journey from concept to commercial production. Use this as a checklist when briefing your OEM manufacturing partner.
Step 1: Choose Raw Material
- Soy PS — lowest cost, mature supply chain, suitable for mass market
- Sunflower PS — 15-25% premium, allergen-free, clean-label premium positioning
- Branded (Sharp-PS / SerinAid) — highest clinical credibility, marketing support, premium pricing
Step 2: Choose Purity Grade
- 20% PS — functional foods, beverages, bulk powder blends; lowest cost per kg but highest inclusion rate
- 50% PS — optimal balance for capsules and tablets; ‘sweet spot’ for most applications
- 70% PS — premium single-capsule products, practitioner channel, maximum potency per unit
Step 3: Choose Dosage
- 100 mg — entry-level, multi-ingredient stacks, gummies
- 200 mg — single-capsule daily, children’s formulas
- 300 mg — clinical strength, practitioner channel
- 400-600 mg — sports recovery, cortisol modulation
Step 4: Choose Delivery Form
- Hard-shell capsules — highest consumer trust; easiest swallowing; standard for 100-300 mg
- Softgels — oil-based co-delivery (PS + DHA); enhanced bioavailability
- Tablets — cost advantage; requires compression expertise for PS
- Gummies — highest compliance among younger demographics; fastest-growing segment
- Liquid/Suspension — flexible dosing; liposomal delivery for premium positioning
- Bulk Powder — lowest cost per serving; for functional food or in-house encapsulation
Step 5: Packaging Configuration
- Primary: HDPE bottles (white/amber), glass bottles, blister cards, stick packs, sachets
- Secondary: Retail cartons, display boxes, shelf-ready packaging
- Label Compliance: Supplement Facts panels, allergen statements, structure/function claims, QR code integration
- Child-Resistant Closures (CRC): Available for higher-safety-profile products
Step 6: Regulatory Positioning
- United States: FDA qualified health claim (with disclaimer) + structure/function claims with 30-day notification
- European Union: EFSA general food law compliance; Novel Food consultation for new sources/formats
- Canada: NPN licensing through Health Canada’s NHPD
- Australia/NZ: TGA listing (AUST L) for low-risk claims
- ASEAN/China: Country-specific registration; China requires ‘Blue Hat’ for functional claims
Step 7: Pilot Batch & Scale-Up
- Prototype Development: 2-4 week turnaround for sample batches
- Stability Testing: ICH Q1A accelerated (40 degrees C / 75% RH, 6 months) + real-time (25 degrees C / 60% RH, 24-36 months)
- Scale-Up: From 25 kg bulk to 10 million+ unit annual contracts
| Product Format | MOQ | Lead Time | Stability Data Available |
| Bulk Powder (20%/50%/70%) | 25 kg | 2-3 weeks | Yes — 24-month real-time |
| Hard-Shell Capsules | 100,000 units | 4-6 weeks | Yes — ICH Q1A + real-time |
| Softgel Capsules | 100,000 units | 5-7 weeks | Yes — ICH Q1A + real-time |
| Tablets | 100,000 units | 4-6 weeks | Yes — ICH Q1A + real-time |
| Gummies | 50,000 units | 6-8 weeks | Yes — ICH Q1A + real-time |
| Liquid / Suspension | 5,000 units | 4-6 weeks | Yes — ICH Q1A + real-time |
| Custom Formulation (R&D) | 1 prototype batch | 2-4 weeks | Upon request |
Ready to Launch Your Phosphatidylserine Product?
From market intelligence and formulation development to commercial production and global fulfillment, KS Nutripharma provides the manufacturing expertise, quality systems, and regulatory support that B2B buyers require — and that YMYL consumers deserve.
Next Steps
- Request a sample of our PS raw materials (soy, sunflower, or branded options)
- Download full specification sheets with CQA tables and stability data summaries
- Book a technical consultation with our R&D team to discuss your formulation requirements
- Schedule a virtual factory tour to review our manufacturing platform and quality systems
Our MOQ for hard-shell capsules and softgels is 100,000 units per SKU. For gummies, 50,000 units. Bulk powder starts at 25 kg. Custom formulation prototype batches are available with no minimum for qualified buyers.
Bulk powder: 2-3 weeks. Capsules and tablets: 4-6 weeks. Softgels: 5-7 weeks. Gummies: 6-8 weeks. Custom formulations: 2-4 weeks for prototypes. Lead times assume raw material in stock; branded ingredients (Sharp-PS, SerinAid) may require additional 2-3 weeks for sourcing.
Yes. We offer sunflower-derived PS that is inherently soy-free and non-GMO. We also offer Sharp-PS GREEN, the leading branded sunflower PS with full clinical validation and trademark licensing.
Yes. Every production batch is accompanied by a batch-specific CoA including: PS assay by HPLC, moisture, peroxide value, heavy metals (Pb, As, Cd, Hg by ICP-MS), microbiology (total plate count, yeast/mould, E. coli, Salmonella), and residual solvents. CoAs include analyst signatures and reference standards.
Third-party testing includes: identity confirmation (HPLC, FTIR, NMR), potency verification (+/-5% tolerance), heavy metals screening (ICP-MS), microbiological testing (USP <2021>/<2022>), residual solvents (USP <467>), and allergen testing (ELISA) where applicable.
Yes. We support the full clinically validated range: 100 mg, 200 mg, 300 mg, and premium strengths of 400-600 mg per serving. Custom dosages outside this range can be developed upon request with appropriate stability validation.
Yes. PS gummy manufacturing is one of our specialties. We use pectin-based vegan matrices, low-temperature processing (<60 degrees C), natural flavor masking with bitterness blockers, and microencapsulated PS to protect potency and mask phospholipid odor. Typical potency: 100 mg per gummy.
Yes. We provide EU-compliant documentation including: Novel Food status consultation (where applicable), EFSA claim compliance review, CE marking for packaging, and full regulatory dossier preparation. Our sunflower-derived PS is particularly well-suited for EU market entry.
Pricing depends on: raw material tier (generic soy / generic sunflower / branded), purity grade (20% / 50% / 70%), dosage form, packaging complexity, and order volume. We offer transparent pricing with no hidden fees and volume-based tier discounts. Contact us for a detailed quotation tailored to your specifications.
